688062.SH
Mabwell (Shanghai) Bioscience Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 21.80
+1.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- -10.05x
- PEG TTM
- —
- Price / book
- 11.15x
- Price / sales
- 12.01x
- Price / cash flow
- -29.07x
Enterprise value
- Enterprise value
- CNY 10.1B
- EV / sales
- 13.49x
- EV / EBITDA
- -13.10x
- EV / EBIT
- -11.13x
- Market cap
- CNY 9.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026